| Income Statement |
| Total Revenue | 2.74M |
|
| Revenues (USD) | 2.74M |
| Cost of Revenue | 1.16M |
| Gross Profit | 1.58M |
| Operating Expenses | 24.96M |
| Research and Development Expense | 9.68M |
| Selling, General and Administrative Expense | 15.10M |
| Operating Income | -23.39M |
| Income Tax Expense | 99.00K |
| Net Income | -22.65M |
| Net Income Common Stock | -22.65M |
| Net Income Common Stock (USD) | -22.65M |
| Consolidated Income | -22.65M |
| Earnings per Basic Share | -0.19 |
| Earnings per Basic Share (USD) | -0.19 |
| Earnings per Diluted Share | -0.19 |
| Earning Before Interest & Taxes (EBIT) | -22.55M |
| Earning Before Interest & Taxes (USD) | -22.55M |
| Weighted Average Shares | 122.38M |
| Weighted Average Shares Diluted | 122.38M |
| Balance Sheet |
| Cash and Equivalents | 33.22M |
| Cash and Equivalents (USD) | 33.22M |
| Trade and Non-Trade Receivables | 16.73M |
| Current Assets | 65.38M |
| Property, Plant & Equipment Net | 2.69M |
| Total Assets | 70.75M |
| Debt Current | 4.95M |
| Total Debt | 5.59M |
| Current Liabilities | 26.54M |
| Debt Non-Current | 640.00K |
| Total Liabilities | 45.31M |
| Accumulated Retained Earnings (Deficit) | -658.81M |
| Accumulated Other Comprehensive Income | 125.00K |
| Shareholders Equity | 25.45M |
| Shareholders Equity (USD) | 25.45M |
| Assets Non-Current | 5.37M |
| Total Debt (USD) | 5.59M |
| Inventory | 9.01M |
| Liabilities Non-Current | 18.77M |
| Trade and Non-Trade Payables | 14.33M |
| Tax Assets | 1.96M |
| Cash Flow |
| Net Cash Flow from Financing | 58.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -12.57M |
| Capital Expenditure | -116.00K |
| Issuance (Purchase) of Equity Shares | 58.00K |
| Net Cash Flow from Investing | -116.00K |
| Net Cash Flow from Operations | -12.63M |
| Effect of Exchange Rate Changes on Cash | 121.00K |